Related Experiment Videos
Dexamethasone: pharmacokinetics in neurological patients
Clinical and Experimental Neurology
|January 1, 1984
Summary
Plasma dexamethasone levels vary significantly in neurological patients, impacting oral bioavailability and treatment effectiveness. Monitoring drug levels is crucial for optimizing therapy and potentially avoiding side effects like adrenal suppression.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Neuroscience
Background:
- Dexamethasone is a steroid commonly used for various neurological disorders.
- Understanding its pharmacokinetics is essential for effective therapeutic use.
- Previous studies have not fully characterized dexamethasone pharmacokinetics in neurological patients.
Purpose of the Study:
- To measure plasma dexamethasone concentrations over time in patients with neurological disorders.
- To compare the pharmacokinetics of dexamethasone in these patients versus healthy volunteers.
- To investigate factors influencing dexamethasone bioavailability and clearance.
Main Methods:
- High-performance liquid chromatography (HPLC) assay used to quantify plasma dexamethasone.
- Time-course measurements of drug concentrations were performed.
- Pharmacokinetic parameters including clearance and bioavailability were analyzed.
Main Results:
- Patients with neurological disorders exhibited higher whole-body clearances of dexamethasone compared to healthy volunteers.
- Oral bioavailability of dexamethasone was substantially impaired with significant inter-individual variability.
- Concurrent phenytoin therapy increased dexamethasone clearance.
Conclusions:
- Impaired oral bioavailability of dexamethasone in neurological patients may lead to apparent steroid resistance.
- Monitoring plasma dexamethasone levels is recommended for therapeutic optimization.
- Potential strategies to mitigate adrenal suppression by manipulating dosing intervals were explored.